Stocktoria
Guardant Health, Inc. GH
Guardant Health, Inc. financials (annual)
Bars are annual figures from 2017 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $982.0M | $739.0M | $563.9M | $449.5M | $373.7M | $286.7M | $214.4M | $90.6M | $49.8M |
| R&D expense | $364.2M | $347.8M | $367.2M | $373.8M | $263.2M | $149.9M | $86.3M | $50.7M | $25.6M |
| Operating income | -$437.2M | -$443.6M | -$564.7M | -$544.4M | -$411.0M | -$254.9M | -$82.4M | -$92.9M | -$76.6M |
| Interest expense | — | — | $2.6M | $2.6M | $2.6M | $4.8M | $1.2M | $1.3M | $2.7M |
| Income tax | -$1.3M | $1.3M | $685,000 | $1.1M | $300,000 | $379,000 | -$1.9M | $38,000 | $7,000 |
| Net income | -$416.3M | -$436.4M | -$479.4M | -$654.6M | -$384.8M | — | -$75.7M | -$85.1M | -$83.2M |
| EPS (diluted) | $-3.32 | $-3.56 | $-4.28 | $-6.41 | $-4.00 | $-2.60 | $-0.84 | — | — |
| Operating cash flow | -$184.8M | -$239.9M | -$325.0M | -$309.5M | -$209.0M | -$103.9M | -$47.1M | -$72.2M | -$72.2M |
| Free cash flow | -$233.1M | -$274.9M | -$345.5M | -$386.9M | -$284.1M | -$140.1M | -$65.9M | -$92.4M | -$78.9M |
| Cash & equivalents | $378.2M | $525.5M | $1.1B | $141.6M | $492.2M | $833.0M | $143.2M | $140.5M | $72.3M |
| Inventory | $85.9M | $71.1M | $61.9M | $51.6M | $30.7M | $22.7M | $15.2M | $9.1M | $7.3M |
| Total assets | $2.0B | $1.5B | $1.8B | $1.6B | $2.2B | $2.3B | $962.5M | $587.4M | $342.9M |
| Total liabilities | $2.1B | $1.6B | $1.6B | $1.5B | $1.6B | $916.2M | $114.5M | $62.5M | $34.3M |
| Shareholders' equity | -$99.3M | -$139.6M | $158.7M | $60.2M | $645.0M | $1.3B | $798.4M | $483.2M | $308.6M |
Growth · year-over-year · Revenue CAGR 45.1%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +32.9% | +31.0% | +25.5% | +20.3% | +30.3% | +33.8% | +136.5% | +81.9% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.